Active ingredient
Denosumab
22 finished FDA listings contain Denosumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- DENOSUMAB, DENOSUMAB-DSSB
- Dosage forms
- Injection, Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 10
- Strengths listed
- 120 mg/1.7ml · 60 mg/ml · 70 mg/ml
- Brand names in FDA listings
- Aukelso, Bildyos, Bilprevda, Bomyntra, Boncresa, Bosaya, Conexxence, Enoby, Jubbonti, Jubereq, Osenvelt, Ospomyv, Osvyrti, Oziltus, Prolia, Stoboclo, Wyost, Xgeva, Xtrenbo
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 993449
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 125320 | AMGEN | 2010-06-01 | 2 |
| BLA 761362 | SANDOZ INC | 2024-03-05 | 2 |
| BLA 761392 | SAMSUNG BIOEPIS CO LTD | 2025-02-13 | 1 |
| BLA 761404 | CELLTRION INC | 2025-02-28 | 4 |
| BLA 761398 | FRESENIUS KABI USA LLC | 2025-03-25 | 3 |
| BLA 761444 | SHANGHAI HENLIUS BIOTECH | 2025-08-29 | 2 |
| BLA 761436 | BIOCON BIOLOGICS INC | 2025-09-16 | 2 |
| BLA 761439 | HIKMA PHARMACEUTICALS USA INC | 2025-09-26 | 2 |
| BLA 761424 | ACCORD BIOPHARMA INC. | 2025-10-29 | 2 |
| BLA 761456 | AMNEAL PHARMS LLC | 2025-12-19 | 1 |
| BLA 761457 | AMNEAL PHARMS LLC | 2025-12-19 | 1 |
Official labeling on DailyMed
- BILPREVDA (DENOSUMAB) INJECTION, SOLUTION [ORGANON LLC] · version 3 · 2026-08-20
- BILDYOS (DENOSUMAB) INJECTION, SOLUTION [ORGANON LLC] · version 3 · 2026-08-20
- BOSAYA (DENOSUMAB-KYQQ) INJECTION [BIOCON BIOLOGICS INC.] · version 3 · 2026-07-30
- AUKELSO (DENOSUMAB-KYQQ) INJECTION [BIOCON BIOLOGICS INC.] · version 3 · 2026-07-30
- JUBEREQ (DENOSUMAB-DESU) INJECTION [ACCORD BIOPHARMA INC.] · version 3 · 2026-07-15
- XGEVA (DENOSUMAB) INJECTION [AMGEN, INC] · version 177 · 2026-07-10
- OSVYRTI (DENOSUMAB-DESU) INJECTION [ACCORD BIOPHARMA INC.] · version 2 · 2026-07-09
- PROLIA (DENOSUMAB) INJECTION [AMGEN, INC] · version 186 · 2026-07-07
- DENOSUMAB-BMWO INJECTION [CELLTRION USA, INC.] · version 4 · 2026-04-23
- DENOSUMAB-BMWO INJECTION [CELLTRION USA, INC.] · version 4 · 2026-04-23
- STOBOCLO (DENOSUMAB-BMWO) INJECTION [CELLTRION USA, INC.] · version 7 · 2026-04-23
- OSENVELT (DENOSUMAB-BMWO) INJECTION [CELLTRION USA, INC.] · version 7 · 2026-04-23
Showing the 12 most recent of 21 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.